Le Lézard
Classified in: Health, Science and technology
Subjects: Conference, Trade Show, Webcast

Rocket Pharmaceuticals Announces Participation at Upcoming Conferences


Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) ("Rocket"), a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces participation at the following upcoming conferences:

A live audio webcast of the presentation will be available on the Investors section of the company's website, www.rocketpharma.com. A replay of the presentation will be archived on the Rocket website following the conferences.

About Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) ("Rocket") is advancing an integrated and sustainable pipeline of genetic therapies that correct the root cause of complex and rare childhood disorders. The company's platform-agnostic approach enables it to design the best therapy for each indication, creating potentially transformative options for patients afflicted with rare genetic diseases. Rocket's clinical programs using lentiviral vector (LVV)-based gene therapy are for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer, Leukocyte Adhesion Deficiency-I (LAD-I), a severe pediatric genetic disorder that causes recurrent and life-threatening infections which are frequently fatal, Pyruvate Kinase Deficiency (PKD) a rare, monogenic red blood cell disorder resulting in increased red cell destruction and mild to life-threatening anemia and Infantile Malignant Osteopetrosis (IMO), a bone marrow-derived disorder. Rocket's first clinical program using adeno-associated virus (AAV)-based gene therapy is for Danon disease, a devastating, pediatric heart failure condition. For more information about Rocket, please visit www.rocketpharma.com.


These press releases may also interest you

at 14:52
Ontario One Call to support better locate performance as Administrative Penalty regulation comes into force May 1, 2024
Ontario One Call (OOC) is working closely with underground infrastructure owners/operators and excavators to usher in a new era of improved locate performance in the province of Ontario....

at 14:33
Melwood, Enabled Intelligence Announce Partnership to Recruit and Train 100 Neurodiverse AI Data Analysts
Enabled Intelligence (EI), a global leader in mission-critical AI data solutions for the US Defense and Intelligence Community today announced a groundbreaking new partnership with Melwood, a leading employer, advocate, and service provider for...

at 14:23
Autolomous and BioCentriq Partner to Speed Up Cell Therapy Delivery
Autolomous, the market-leading developer of critical manufacturing management systems for cell and gene therapies, and BioCentriq, industry-leading clinical-phase Cell Therapy CDMO (contract development and manufacturing organization), announce a...

at 14:08
Seacoast Laboratory Data Systems Announces new KPI Report Dashboard for SurroundLab AR
Seacoast Laboratory Data Systems, a nationwide leader in providing customizable LIS and AR software solutions for commercial and...

at 14:05
Transflo Wins 2024 Top Workplaces Culture Excellence Awards for Innovation, Work-Life Flexibility, Leadership
Transflo, a leading provider of technology solutions for the transportation industry, is thrilled to announce that it has won three 2024 Top Workplaces Culture Excellence awards. The honors are awarded by Energage, a purpose-driven organization that...

at 14:05
Coalition Finds More Than Half of Cyber Insurance Claims Originate in the Email Inbox
Coalition, the world's first Active Insurance provider designed to prevent digital risk before it strikes, today published its 2024 Cyber Claims Report, which details emerging cyber trends and their impact on Coalition policyholders throughout 2023....

More news about Science and technology...


News published on and distributed by: